So what do I really think? The company had clearly turned the corner (revenue, profit, pipeline etc) but the Lanett situation created an extension for Mr short pants. They thought they knew all the cards.
They saw an opportunity to continue this charade while long investors like myself saw the market cap vs assets, earnings, revenue, and pipeline not making any sense. But it's OTC right?
Why jour_trader liked to tell me I don't understand OTC. And that the CEO is incompetent because he came in 2m over what he stated on the call. Really , he's just mad. And he's got a problem like the team does.
A tidbit on the incompetent CEO vs the numbers. Did he miss this part from the conference call
We had Isradipine being sold by another company first Glenmark and then Epic. The revenues from Isradipine for the entire year last year when the product was under another company are less than what we got in one month under Kirko. When you have your own product and you care, then you invest more time and effort into selling your product and in their profitability.
But nah, he's just incompetent or is jour_trader just mad as his situation?
Now, anyone invested in the company paid attention to it. Why? Because that shit pays the bills and then some. Isradipine is a smaller drug. But not a lot of competition. We have a bunch of those and some pending approval now. This is what a business owner understands. We are hitting home runs now. Adderall is a home run and so is OXY and the others.
But he's putting solid revenue for a small cap company just on those products. And now maximizing profit and revenues and has a path to beat the competition with their own label and marketing/sales. And Kirkov has the ability. How many drugs did Epic have when they were sold? Some of the same in fact.
So Mr short pants thought they had more time, we were supposed to have a down quarter, lower profit if much at all. But they got fooled by the incompetent CEO. Lol
